Publication Name	World Journal of Diabetes
Manuscript ID	90495
Country	Italy

Received	2023-12-05 15:39
Peer-Review Started	2023-12-05 15:39
To Make the First Decision
Return for Revision	2024-02-02 06:32
Revised	2024-02-15 09:20
Second Decision	2024-03-18 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-03-18 05:36
Articles in Press	2024-03-18 05:36
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-29 00:23
Publish the Manuscript Online	2024-05-10 11:51

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth?
Manuscript Source	Invited Manuscript
All Author List	Lorenzo Nesti and Domenico Trico
ORCID	Author(s) ORCID Number Lorenzo Nesti http://orcid.org/0000-0002-0560-6496 Domenico Trico http://orcid.org/0000-0002-7633-1346
Funding Agency and Grant Number
Corresponding Author	Domenico Trico, MD, PhD, Assistant Professor, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, Pisa 56126, Italy. domenico.trico@unipi.it
Key Words	Atherosclerosis; Cardiovascular system; Glucagon-like peptide-1; Heart failure; Tirzepatide; Type 2 diabetes; Ventricular function, Left
Core Tip	A growing body of evidence supports the potential cardioprotective properties of glucagon-like peptide 1 receptor agonists (GLP1-RAs) beyond glycemic control, especially in the context of cardiovascular disease. Although the effects of these drugs are consistent in reducing atherosclerosis-related diseases, there is an ongoing debate about the validity of the claim that GLP1-RAs have cardioprotective benefits in heart failure (HF)–a topic that sparks both enthusiasm and skepticism in the scientific and medical communities. Herein we provide a narrative review of the available evidence on the cardioprotective actions of GLP1-RAs in patients with HF, summarizing clinical findings and proposed mechanisms.
Publish Date	2024-05-10 11:51
Citation	Nesti L, Trico D. Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth? World J Diabetes 2024; 15(5): 818-822
URL	https://www.wjgnet.com/1948-9358/full/v15/i5/818.htm
DOI	10.4239/wjd.v15.i5.818

Full Article (PDF)	WJD-15-818-with-cover.pdf
Full Article (Word)	WJD-15-818.docx
Manuscript File	90495_Auto_Edited-YJP.docx
Answering Reviewers	90495-Answering reviewers.pdf
Audio Core Tip	90495-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90495-Conflict-of-interest statement.pdf
Copyright License Agreement	90495-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90495-Language certificate.pdf
Peer-review Report	90495-Peer-review(s).pdf
Scientific Misconduct Check	90495-Bing-Li L-2.png
Scientific Editor Work List	90495-Scientific editor work list.pdf
CrossCheck Report	90495-CrossCheck.png
CrossCheck Report	90495-CrossCheck report.pdf